Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Sphera Funds Management Ltd.
Form 13F · Q2 2026

Sphera Funds Management Ltd.

CIK 1496201申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$7.7亿
申報組合市值
106
持倉數量
12
Quarters on record
Top 50
持倉數量

Sphera Funds Management Ltd.——持倉

共 106 個持倉中的前 50 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1TEVA Teva Pharmaceutical Inds Ltd1.5M+31.9%$5082万6.6%
2MLYS Mineralys Therapeutics Inc1.5M+9.7%$3966万5.2%
3TSEM Tower Semiconductor Ltd108,265−25.7%$2822万3.7%
4SNDX Syndax Pharmaceuticals Inc1.0M+40.0%$2218万2.9%
5BIIB Biogen Inc96,626+4.4%$2088万2.7%
6RARE Ultragenyx Pharmaceutical In588,494−27.3%$1965万2.6%
7BMRN Biomarin Pharmaceutical Inc328,550+134.8%$1880万2.5%
8CYTK Cytokinetics Inc219,987+452.5%$1874万2.4%
9BBIO Bridgebio Pharma Inc245,346+0.0%$1827万2.4%
10COGT Cogent Biosciences Inc459,340+10.3%$1778万2.3%
11NVMI Nova Ltd25,169−52.8%$1367万1.8%
12INSM Insmed Inc118,800—$1267万1.7%
13MAZE Maze Therapeutics Inc417,564+83.7%$1246万1.6%
14AZN Astrazeneca Plc62,530+0.0%$1186万1.5%
15SNY Sanofi Sa269,515+0.0%$1150万1.5%
16HELP Cybin Inc1.6M+64.2%$1071万1.4%
17LLY Eli Lilly & Co8,040−11.1%$964万1.3%
18MDGL Madrigal Pharmaceuticals Inc17,419+92.7%$935万1.2%
19TRVI Trevi Therapeutics Inc499,029−13.1%$931万1.2%
20ACAD Acadia Pharmaceuticals Inc356,534+39.2%$902万1.2%
21CLDX Celldex Therapeutics Inc New240,868−1.1%$896万1.2%
22RYTM Rhythm Pharmaceuticals Inc80,400—$893万1.2%
23ORIC Oric Pharmaceuticals Inc752,983+40.1%$815万1.1%
24LRCX Lam Research Corp18,470—$800万1.0%
25AMAT Applied Matls Inc11,040—$798万1.0%
26TNGX Tango Therapeutics Inc254,250−26.0%$795万1.0%
27NVS Novartis Ag50,000+35.1%$783万1.0%
28SEDG Solar Edge Technologies 2.25 07/01/20294.0M+0.0%$775万1.0%
29VOR Vor Biopharma Inc416,417+29.4%$767万1.0%
30ABBV Abbvie Inc30,256+0.0%$761万1.0%
31MRK Merck & Co Inc58,600+20.6%$753万1.0%
32JNJ Johnson & Johnson28,831+0.0%$732万1.0%
33IDYA Ideaya Biosciences Inc196,408—$732万1.0%
34IMTX Immatics N.V720,057+3.4%$729万1.0%
35NVCT Nuvectis Pharma Inc382,945—$704万0.9%
36PFE Pfizer Inc286,000+53.8%$689万0.9%
37HRMY Harmony Biosciences Hldgs In176,663—$643万0.8%
38XENE Xenon Pharmaceuticals Inc105,000−17.3%$634万0.8%
39CLYM Climb Bio Inc483,747+15.4%$631万0.8%
40ZBIO Zenas Biopharma Inc230,834+7.7%$586万0.8%
41NVO Novo-Nordisk A S120,677+0.0%$579万0.8%
42ELVN Enliven Therapeutics Inc112,765−26.4%$572万0.7%
43PRLD Prelude Therapeutics Inc1.0M+82.7%$544万0.7%
44GSK Gsk Plc102,000−16.4%$535万0.7%
45FORTE BIOSCIENCES INC Forte Biosciences Inc249,693+35.0%$531万0.7%
46BIOA Bioage Labs Inc213,671+147.0%$524万0.7%
47SRRK Scholar Rock Hldg Corp94,265+0.0%$518万0.7%
48MSLE Satellos Bioscience Inc652,590+33.4%$507万0.7%
49PALI Palisade Bio Inc2.3M+30.2%$472万0.6%
50ELDN Eledon Pharmaceuticals Inc1.2M−32.8%$469万0.6%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。